FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283715570> ?p ?o ?g. }

• W4283715570 endingPage "1841" @default.
• W4283715570 startingPage "1834" @default.
• W4283715570 abstract "Rationale: In chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICS) are associated with pneumonia, highlighting the importance of investigating subgroups of patients who may benefit from prolonged ICS use. Despite this, the WISDOM (Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management) trial found a greater decline in forced expiratory volume in 1 second (FEV1) in patients with COPD who withdrew from ICS compared with patients who remained on triple therapy. Objectives: We investigated the association between ICS withdrawal and the rate of FEV1 decline in patients with COPD using routinely collected electronic healthcare records. Methods: Using CPRD (Clinical Practice Research Datalink) Aurum and Hospital episode statistics, we included patients with COPD who had been on triple therapy for at least 4 months. Patients were categorized into those who withdrew from ICS and those who remained on triple therapy during follow-up. Three cohorts were created: 1) patients meeting the WISDOM trial eligibility criteria; 2) patients with COPD not restricted by the WISDOM trial eligibility criteria; and 3) patients who would have been excluded from the WISDOM trial on the basis of their comorbidities. Mixed linear regression was used to model the association between ICS withdrawal and the rate of FEV1 decline (ml/year) adjusted for baseline characteristics. Results: A total of 6,008 patients with COPD met the WISDOM eligibility criteria, of which 9.0% withdrew from ICS. Mean rates of FEV1 declined −7.8 ml/year (95% confidence interval [CI], −19.7 to 4.1) for withdrawers and −15.2 ml/year (95% CI, −18.7 to −11.8) for those who remained on triple therapy (difference, P = 0.264). A total of 60,645 patients with COPD were not restricted by the WISDOM eligibility criteria. The mean rate of FEV1 decline was −32.6 ml/year (95% CI, −33.6 to −31.5) for withdrawers and −36.4 ml/year (95% CI, −39.4 to −33.4) for those who remained on triple therapy. A total of 32,882 patients with COPD were included in the last population representing those who would have been excluded from the WISDOM trial because of their comorbidities. The mean rate of FEV1 decline was −29.4 ml/year (95% CI, −30 to −28.1) in withdrawers and −31.3 ml/year (95% CI, −35 to −27.5) in those who remained on triple therapy. Conclusions: The rate of FEV1 decline was similar between patients on triple therapy and patients who withdrew from ICS regardless of the specific COPD population studied. In routine clinical practice, few patients with COPD meet WISDOM eligibility criteria, and few patients are withdrawn from ICS." @default.
• W4283715570 created "2022-07-01" @default.
• W4283715570 creator A5009248763 @default.
• W4283715570 creator A5027385508 @default.
• W4283715570 creator A5046531226 @default.
• W4283715570 creator A5069614553 @default.
• W4283715570 creator A5076213012 @default.
• W4283715570 date "2022-11-01" @default.
• W4283715570 modified "2023-09-30" @default.
• W4283715570 title "Inhaled Corticosteroid Withdrawal and Change in Lung Function in Primary Care Patients with Chronic Obstructive Pulmonary Disease in England" @default.
• W4283715570 cites W1479859260 @default.
• W4283715570 cites W2064899799 @default.
• W4283715570 cites W2078552229 @default.
• W4283715570 cites W2081180334 @default.
• W4283715570 cites W2101978351 @default.
• W4283715570 cites W2122286642 @default.
• W4283715570 cites W2127104182 @default.
• W4283715570 cites W2136593482 @default.
• W4283715570 cites W2142724633 @default.
• W4283715570 cites W2153976816 @default.
• W4283715570 cites W2168315832 @default.
• W4283715570 cites W2172005465 @default.
• W4283715570 cites W2545458768 @default.
• W4283715570 cites W2613646221 @default.
• W4283715570 cites W2763244509 @default.
• W4283715570 cites W2767263702 @default.
• W4283715570 cites W2794418690 @default.
• W4283715570 cites W2804974357 @default.
• W4283715570 cites W2883486412 @default.
• W4283715570 cites W2892615536 @default.
• W4283715570 cites W3014183580 @default.
• W4283715570 cites W3023692150 @default.
• W4283715570 cites W3026537932 @default.
• W4283715570 cites W3120737064 @default.
• W4283715570 cites W3149026346 @default.
• W4283715570 doi "https://doi.org/10.1513/annalsats.202111-1238oc" @default.
• W4283715570 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35767034" @default.
• W4283715570 hasPublicationYear "2022" @default.
• W4283715570 type Work @default.
• W4283715570 citedByCount "4" @default.
• W4283715570 countsByYear W42837155702022 @default.
• W4283715570 countsByYear W42837155702023 @default.
• W4283715570 crossrefType "journal-article" @default.
• W4283715570 hasAuthorship W4283715570A5009248763 @default.
• W4283715570 hasAuthorship W4283715570A5027385508 @default.
• W4283715570 hasAuthorship W4283715570A5046531226 @default.
• W4283715570 hasAuthorship W4283715570A5069614553 @default.
• W4283715570 hasAuthorship W4283715570A5076213012 @default.
• W4283715570 hasBestOaLocation W42837155702 @default.
• W4283715570 hasConcept C126322002 @default.
• W4283715570 hasConcept C1862650 @default.
• W4283715570 hasConcept C2776042228 @default.
• W4283715570 hasConcept C2776780178 @default.
• W4283715570 hasConcept C2776804153 @default.
• W4283715570 hasConcept C2777104659 @default.
• W4283715570 hasConcept C2780911369 @default.
• W4283715570 hasConcept C2781018748 @default.
• W4283715570 hasConcept C44249647 @default.
• W4283715570 hasConcept C71924100 @default.
• W4283715570 hasConcept C75603125 @default.
• W4283715570 hasConceptScore W4283715570C126322002 @default.
• W4283715570 hasConceptScore W4283715570C1862650 @default.
• W4283715570 hasConceptScore W4283715570C2776042228 @default.
• W4283715570 hasConceptScore W4283715570C2776780178 @default.
• W4283715570 hasConceptScore W4283715570C2776804153 @default.
• W4283715570 hasConceptScore W4283715570C2777104659 @default.
• W4283715570 hasConceptScore W4283715570C2780911369 @default.
• W4283715570 hasConceptScore W4283715570C2781018748 @default.
• W4283715570 hasConceptScore W4283715570C44249647 @default.
• W4283715570 hasConceptScore W4283715570C71924100 @default.
• W4283715570 hasConceptScore W4283715570C75603125 @default.
• W4283715570 hasFunder F4320306257 @default.
• W4283715570 hasIssue "11" @default.
• W4283715570 hasLocation W42837155701 @default.
• W4283715570 hasLocation W42837155702 @default.
• W4283715570 hasLocation W42837155703 @default.
• W4283715570 hasOpenAccess W4283715570 @default.
• W4283715570 hasPrimaryLocation W42837155701 @default.
• W4283715570 hasRelatedWork W2083414123 @default.
• W4283715570 hasRelatedWork W2132078152 @default.
• W4283715570 hasRelatedWork W2184557701 @default.
• W4283715570 hasRelatedWork W2552894938 @default.
• W4283715570 hasRelatedWork W2940473654 @default.
• W4283715570 hasRelatedWork W3028948273 @default.
• W4283715570 hasRelatedWork W3046024349 @default.
• W4283715570 hasRelatedWork W3206428628 @default.
• W4283715570 hasRelatedWork W4232328075 @default.
• W4283715570 hasRelatedWork W4248150072 @default.
• W4283715570 hasVolume "19" @default.
• W4283715570 isParatext "false" @default.
• W4283715570 isRetracted "false" @default.
• W4283715570 workType "article" @default.